What did Smith & Nephew pay for Integra LifeSciences' Extremity Orthopaedics Business?

Smith & Nephew acquired Integra LifeSciences' Extremity Orthopaedics Business for $236.0M in 2021, equivalent to 2.60x revenue. Target revenue was approximately $90.0M.

What multiple did Smith & Nephew pay for Integra LifeSciences' Extremity Orthopaedics Business?

2.60x revenue, based on disclosed deal value of $236.0M and disclosed financials.

M&A TRANSACTION · 2021

Integra LifeSciences' Extremity Orthopaedics Business acquired by Smith & Nephew

$236.0M· 2.60x revenue

Target

Integra LifeSciences' Extremity Orthopaedics Business

Acquirer

Smith & Nephew

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$90.0M

EBITDA

—

Deal Value

$236.0M

EV/EBITDA

—

Context

This $236.0M acquisition of Integra LifeSciences' Extremity Orthopaedics Business by Smith & Nephew sits in the medical devices sub-vertical. Smith & Nephew is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Integra LifeSciences' Extremity Orthopaedics Business acquisition.

Citation: ExitValue.ai. (2021). Integra LifeSciences' Extremity Orthopaedics Business acquired by Smith & Nephew. https://exitvalue.ai/deals/integra-lifesciences-extremity-orthopaedics-busine-acquired-by-smith-nephew-hc-2021-0110